Top Qs
Timeline
Chat
Perspective
Aviv Regev
Bioinformatician From Wikipedia, the free encyclopedia
Remove ads
Aviv Regev (Hebrew: אביב רגב; born 11 July 1971)[1] is a computational biologist and systems biologist and Executive Vice President and Head of Genentech Research and Early Development in Genentech/Roche.[4] She is a core member (on leave) at the Broad Institute of MIT and Harvard and professor (on leave) at the Department of Biology of the Massachusetts Institute of Technology.[5] Regev is a pioneer of single cell genomics and of computational and systems biology of gene regulatory circuits. She founded and leads the Human Cell Atlas project,[6] together with Sarah Teichmann. Since 2024, she has served as a scientific advisory board member of Arc Institute.[7]
.jpg)
Remove ads
Education
Regev studied at the Adi Lautman Interdisciplinary Program for Outstanding Students of Tel Aviv University, where she completed her PhD under the supervision of Eva Jablonka,[8] and Ehud Shapiro.[9]
Career and research
Summarize
Perspective
In 2020, Regev became the head and executive vice president of Genentech Research and Early Development, based in South San Francisco, and a member of the extended corporate executive committee of Roche.[10][11] Previously, she was a Core Institute Member (now on leave), chair of the Faculty, founding director of the Klarman Cell Observatory and co-director Cell Circuits Program at the Broad Institute of MIT and Harvard. She was also a professor in the Department of Biology at the Massachusetts Institute of Technology (now on leave), as well as an investigator at the Howard Hughes Medical Institute. Regev's research[12] includes work on gene expression[13][14] (with Eran Segal and David Botstein), and the use of π-calculus to represent biochemical processes.[15][16][17] Regev's team has been a leading pioneer of single-cell genomics experimental and computational methods.[18] In 2014, she pitched the idea of the creation of Human Cell Atlas,[19] a project to describe all cell types in the human body. Regev founded the Human Cell Atlas together with Sarah Teichmann along with collaborators all over the world.[20]
Single Cell Genomics
Regev's lab pioneered the development and application of many of the key experimental and computational advances for single cell and spatial genomics, especially single cell RNA-Seq (scRNA-seq).
Awards and honors
Regev is a fellow of the International Society of Computational Biology (ISCB) (2017),[21] a Helmholtz Fellow (2020),[22] and a fellow of the American Association for Cancer Research (AACR) (2021).[23] She is a member of the US National Academy of Sciences (NAS, elected 2019)[24] and of the US National Academy of Medicine (NAM, elected 2020).[25] She was elected as a foreign member of the Royal Society [26] and as an associate member of the European Molecular Biology Organization in 2024.[27]
- William B. Coley Award for Distinguished Research in Basic and Tumor Immunology, 2025[28]
- Streisinger Memorial Lecture, 2025[29]
- Sune Bergström Award, 2025 [30]
- Shai Shacknai Memorial Prize and Lectureship in Immunology and Cancer Research, 2024 [31]
- TED AI 2023 Talk: Can AI Help Develop New Medicines[32][33]
- 25th L'Oréal-UNESCO For Women in Science Awards (Laureate for North America), 2023[34]
- Elected to the American Academy of Arts and Sciences, 2022[35]
- Anderson Lecture, University of Virginia, 2022[36]
- Nakasone Award from the Human Frontiers Science Program (2022)[37]
- Honorary doctorate, ETH Zurich (2021)[38]
- Ernst Schering Prize (2021)[39]
- James Prize in Science and Technology Integration, National Academy of Sciences (2021)[40]
- Vanderbilt Prize (2021)[41]
- She was awarded the 25th Keio Medical Science Prize in 2020.[42][43]
- AACR-Irving Weinstein Foundation Distinguished Lecture (2021)[44]
- Lurie Prize from the Foundation for the NIH (FNIH) (2020)[45]
- Mendel Lecture, European Society of Human Genetics (2020)[46]
- Jonathan Kraft Prize from Massachusetts General Hospital (2020)[47]
- FASEB Excellence in Science Mid-Career Investigator Award (2019)[48]
- She was elected a member of the National Academy of Sciences (NAS) in 2019.[49]
- She also served on the Life Sciences jury for the Infosys Prize in 2018.
- Weatherall Lecture, University Oxford, UK (2018)[50]
- Harvey Lecture, Harvey Society, New York (2018)[51]
- McCormick Lecture, Stanford University (2018)[52]
- Paul Marks Prize for Cancer Research (2017).[53]
- ISCB Innovator Award in 2017.[3][54]
- Earl and Thressa Stadtman Scholar Award from the American Society of Biochemistry and Molecular Biology (ASBMB) (2014)[55]
- Burroughs Wellcome Fund Career Award.[56]
- In 2008, she was also awarded the NIH Director's Pioneer Award.[57][58]
- Regev was awarded the Overton Prize in 2008 for "outstanding accomplishment to a scientist in the early to mid stage of his or her career".[2]
Remove ads
References
Wikiwand - on
Seamless Wikipedia browsing. On steroids.
Remove ads